BNP Paribas Financial Markets Acquires 1,167,558 Shares of ARK Genomic Revolution ETF $ARKG

BNP Paribas Financial Markets grew its holdings in ARK Genomic Revolution ETF (BATS:ARKG) by 49.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,514,980 shares of the company’s stock after purchasing an additional 1,167,558 shares during the period. BNP Paribas Financial Markets owned about 0.08% of ARK Genomic Revolution ETF worth $101,829,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also modified their holdings of the business. FWL Investment Management LLC increased its holdings in shares of ARK Genomic Revolution ETF by 17.1% in the 3rd quarter. FWL Investment Management LLC now owns 3,239 shares of the company’s stock worth $90,000 after purchasing an additional 474 shares in the last quarter. Allworth Financial LP increased its holdings in shares of ARK Genomic Revolution ETF by 39.9% in the 4th quarter. Allworth Financial LP now owns 2,061 shares of the company’s stock worth $60,000 after purchasing an additional 588 shares in the last quarter. Wealthcare Advisory Partners LLC boosted its stake in shares of ARK Genomic Revolution ETF by 4.1% in the 3rd quarter. Wealthcare Advisory Partners LLC now owns 16,327 shares of the company’s stock worth $453,000 after buying an additional 649 shares during the last quarter. Wealth Enhancement Advisory Services LLC boosted its stake in shares of ARK Genomic Revolution ETF by 4.0% in the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 17,394 shares of the company’s stock worth $522,000 after buying an additional 668 shares during the last quarter. Finally, Daymark Wealth Partners LLC boosted its stake in shares of ARK Genomic Revolution ETF by 8.7% in the 4th quarter. Daymark Wealth Partners LLC now owns 8,701 shares of the company’s stock worth $252,000 after buying an additional 700 shares during the last quarter.

ARK Genomic Revolution ETF Stock Performance

ARKG stock opened at $34.64 on Monday. ARK Genomic Revolution ETF has a 1 year low of $20.46 and a 1 year high of $35.12. The stock’s fifty day moving average price is $28.99 and its 200-day moving average price is $29.46.

About ARK Genomic Revolution ETF

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.